icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm
28 Apr, 2009 09:00

Pharmstandard posts FY 2008 Net Profit of 3.5 billion Roubles

Pharmstandard posts FY 2008 Net Profit of 3.5 billion Roubles

Russian drugmaker, Pharmstandard, has posted a FY 2008 Net Profit of 3.5 billion Roubles under IFRS.

The bottom line was up 7% on the FY 2007 Net Profit with EBITDA rising 24% to 6.04 billion Roubles on Revenues of 14.47 billion Roubles, up 26%.

The company attributed the result to a promotional campaign on a range of products including anti viral drug Arbidol, and increase synergies stemming from the decision to transfer production of key drugs including Arbidol and Flukostat to Pharmstandard’s own production facilities.

Podcasts
0:00
23:13
0:00
25:0